Senolytic therapies targeting anti-apoptotic pathways can eliminate senescent cells and enhance chemoradiotherapy efficacy of cancer 10,32
BPC-157 for controlled in vitro laboratory research
It has gained attention in research communities due to its unique structure and broad interest in experimental studies involving tissue pathways, recovery models, and peptide interactions
Weight regain following sleeve gastrectomy-a systematic review
Tesamorelin was developed under the brand name Egrifta and received FDA approval for reducing excess visceral fat in HIV-associated lipodystrophy, making it one of the few GHRH analogs with both clinical trial data and regulatory approval behind it
IGF1-LR3, a modified version of insulin-like growth factor-1, has a longer half-life than standard IGF-1 because it does not bind to IGF-1 binding proteins well